$60.81
Price
$5.8B
Market Cap
—
P/E Ratio
-13.8
Forward P/E
$-5.54
EPS (TTM)
—
Dividend Yield
$1.9B
Cash
$224M
Total Debt
95M
Shares Out
$30.04
$78.48
52-Week Range
Institutional Ownership of CRISPR Therapeutics AG
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for CRISPR Therapeutics AG
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for CRISPR Therapeutics AG
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.